Showing 20 of 136 recruiting trials for “plasmablastic-lymphoma”
Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) With or Without Rituximab Plus Recombinant Erwinia Asparaginase (JZP458) for the Treatment of Newly Diagnosed Ph Negative B-Acute Lymphoblastic Leukemia or T Acute Lymphoblastic Leukemia
👨⚕️ Ryan D. Cassaday, MD, Fred Hutch/University of Washington Cancer Consortium📍 1 site📅 Started Apr 2026View details ↗
Golidocitinib Versus Placebo as Maintenance Therapy for Peripheral T-Cell Lymphoma
Transcutaneous Auricular Vagus Nerve Stimulation for Insomnia in Survivors of Childhood Acute Lymphoblastic Leukemia
👨⚕️ Justin E Tanner, PhD, St. Jude Children's Research Hospital📍 1 site📅 Started Mar 2026View details ↗
Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma
👨⚕️ Jonathan Brammer, MD, Ohio State University Comprehensive Cancer Center📍 1 site📅 Started Feb 2026View details ↗
RecruitingNCT07422337 ↗
A Multi-site Study to Evaluate the Persistence of Protective Immunity to Routine Childhood Vaccinations in Participants With B-ALL/Ly Who Have Received Blinatumomab
👨⚕️ Lauren Appell, MD, Arkansas Children's Research Institute📍 2 sites📅 Started Jan 2026View details ↗
Clinical Trial of CMD63 Chimeric Antigen Receptor T-cell (CAR T-cell) in Children With Acute Lymphoblastic Leukemia (ALL)
👨⚕️ Kanhatai Chiengthong, MD, King Chulalongkorn Memorial Hospital📍 3 sites📅 Started Jan 2026View details ↗
Telematic Cognitive Training and Mindfulness in Pediatric Patients After CAR-T Cell Therapy, Single Hematopoietic Allogeneic Transplant or Chemotherapy
A Study of Subcutaneous Blinatumomab in Children With R/R and and MRD+ B-Cell Precursor Acute Lymphoblastic Leukemia
Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia
Constitutive IL7R (C7R) Modified Banked Allogeneic CD30.CAR EBVSTS for CD30-Positive Lymphomas
A Study of Fludarabine Dosing in Children and Young Adults With B-cell Acute Lymphoblastic Leukemia
👨⚕️ Kevin Curran, MD, Memorial Sloan Kettering Cancer Center📍 3 sites📅 Started Oct 2025View details ↗
Children's Laughter and Fun Yoga as Adjunctive Pain Relief Following Chemotherapy.
👨⚕️ Bahaa W Bou Dargham, MD, Beirut Arab University and Hammoud Hospital University Medical Center📍 1 site📅 Started Oct 2025View details ↗
A Study of CTD402 in T-ALL/LBL Patients
Efficacy of Targeted Drugs Combined With Chemotherapy in the Treatment of T-ALL
👨⚕️ Qifa Liu, Nanfang Hospital, Southern Medical University📍 1 site📅 Started Oct 2025View details ↗
HEM-iSMART-B: Dasatinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies
A Clinical Study Evaluating the Safety and Efficacy of GT801 Injection in Adult Patients With Relapsed/Refractory CD19-positive B-cell Hematologic Malignancies and Autoimmune Hemolytic Anemia
A Phase 2 Study to Evaluate Efficacy of Calaspargase Pegol-mknl and Decitabine Combined With Venetoclax in Pediatric, Adolescent, and Young Adult Patients With Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia (T-ALL) and T- Cell Lymphoblastic Lymphoma (T-LLy)
A Study of Alectinib and Duvelisib in People With Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma (ALK+ALCL)
👨⚕️ Robert Stuver, MD, Memorial Sloan Kettering Cancer Center📍 7 sites📅 Started Aug 2025View details ↗
Effectiveness and Safety of Blinatumomab and Donor Lymphocyte Infusion in Maintenance Therapy After Allogeneic Hematopoietic Stem Cell Transplantation for High-risk Ph Negative B Cell Acute Lymphoblastic Leukemia
CD19 Chimeric Antigen Receptor (CAR) T Cells in Adults With Relapsed/Refractory CD19 Positive Acute Lymphoblastic Leukemia
Page 1 of 7Next →
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →